STAT3 and Alzheimer disease: Similarly, in the AD mouse model, the p-JAK2/JAK2 and p-STAT3/STAT3 values were significantly reduced after LILRB4 knockdown (Fig. 5D), indicating that LILRB4 silencing inhibited JAK2/STAT3 pathway activation.